Authorisation of cancer treatments
The European Medicines Agency
Within the European Union, all cancer drugs need to be approved by the European Medicines Agency. However, the availability and price of each cancer drug may vary from country to country.
Cancer treatments approved in Europe
By clicking on the links below you will leave our website and will be transferred to the website of the European Medicines Agency.
Look for your cancer type (if you do not know the exact medical term you may ask your doctor) to find which medicines are authorized by the European Medicines Agency.
To find if a particular medicine is reimbursed in your country, please check our Availability webpage or your National Medicines Organisation website.
Please print out this information and discuss with your doctor.
- Adrenal cortex neoplasms (adrenal cortex cancer)
- Breast neoplasms (breast cancer)
- Carcinoid tumors
- Carcinoma, basal cell
- Carcinoma, non-small-cell lung
- Carcinoma, small cell lung
- Carcinoma, renal cell
- Carcinoma, hepatocellular
- Carcinoma, transitional cell (bladder cancer)
- Cervical neoplasms (cervical cancer)
- Colonic neoplasms (colon cancer)
- Colorectal neoplasms (colorectal cancer)
- Hodgkin disease
- Gastric adenocarcinoma
- Gastrointestinal stromal tumours
- Leukemia, lymphocytic, chronic, B-Cell
- Leukemia, myeloid
- Meningeal neoplasms
- Multiple myeloma
- Neuroendocrine tumors (including Merkel cell carcinoma)
- Ovarian neoplasms (ovarian cancer)
- Pancreatic neoplasms (pancreatic cancer)
- Parathyroid neoplasms
- Prostatic neoplasms (prostate cancer)
- Stomach neoplasms (stomach cancer)
- Sarcoma, renal-cell sarcoma (renal-cell carcinoma)
- Sarcoma, Kaposi's (Kaposi sarcoma)
- Thyroid neoplasms (thyroid cancer)